Subjective and hormonal effects of 3, 4-methylenedioxymethamphetamine (MDMA) in humans DS Harris, M Baggott, JH Mendelson, JE Mendelson, RT Jones Psychopharmacology 162, 396-405, 2002 | 292 | 2002 |
Test–retest reliability of behavioral measures of impulsive choice, impulsive action, and inattention. J Weafer, MJ Baggott, H de Wit Experimental and clinical psychopharmacology 21 (6), 475, 2013 | 280 | 2013 |
Cardiovascular effects of 3, 4-methylenedioxymethamphetamine: a double-blind, placebo-controlled trial SJ Lester, M Baggott, S Welm, NB Schiller, RT Jones, E Foster, ... Annals of Internal Medicine 133 (12), 969-973, 2000 | 177 | 2000 |
Buprenorphine and naloxone interactions in opiate‐dependent volunteers J Mendelson, RT Jones, I Fernandez, S Welm, AK Melby, MJ Baggott Clinical Pharmacology & Therapeutics 60 (1), 105-114, 1996 | 167 | 1996 |
Chemical analysis of ecstasy pills M Baggott, B Heifets, RT Jones, J Mendelson, E Sferios, J Zehnder Jama 284 (17), 2190-2190, 2000 | 161 | 2000 |
Psychopharmacology of theobromine in healthy volunteers MJ Baggott, E Childs, AB Hart, E de Bruin, AA Palmer, JE Wilkinson, ... Psychopharmacology, 2013 | 144 | 2013 |
Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers J Mendelson, RT Jones, S Welm, M Baggott, I Fernandez, AK Melby, ... Psychopharmacology 141, 37-46, 1999 | 133 | 1999 |
A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction GP Galloway, R Buscemi, JR Coyle, K Flower, JD Siegrist, LA Fiske, ... Clinical Pharmacology & Therapeutics 89 (2), 276-282, 2011 | 110 | 2011 |
The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants? AK Bershad, MA Miller, MJ Baggott, H de Wit Journal of Psychopharmacology 30 (12), 1248-1258, 2016 | 108 | 2016 |
Use patterns and self-reported effects of Salvia divinorum: an internet-based survey MJ Baggott, E Erowid, F Erowid, GP Galloway, J Mendelson Drug and alcohol dependence 111 (3), 250-256, 2010 | 104 | 2010 |
Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire MJ Baggott, JR Coyle, E Erowid, F Erowid, LC Robertson Drug and alcohol dependence 114 (1), 61-67, 2011 | 95 | 2011 |
Mechanisms and genetics of antipsychotic‐associated weight gain SL Balt, GP Galloway, MJ Baggott, Z Schwartz, J Mendelson Clinical Pharmacology & Therapeutics 90 (1), 179-183, 2011 | 76 | 2011 |
MDMA effects consistent across laboratories MG Kirkpatrick, MJ Baggott, JE Mendelson, GP Galloway, ME Liechti, ... Psychopharmacology 231, 3899-3905, 2014 | 73 | 2014 |
Intimate insight: MDMA changes how people talk about significant others MJ Baggott, MG Kirkpatrick, G Bedi, H de Wit Journal of Psychopharmacology 29 (6), 669-677, 2015 | 60 | 2015 |
Effects of 3, 4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting MJ Baggott, JR Coyle, JD Siegrist, KJ Garrison, GP Galloway, ... Journal of psychopharmacology 30 (4), 378-387, 2016 | 57 | 2016 |
Preventing problems in ecstasy users: Reduce use to reduce harm MJ Baggott Journal of Psychoactive Drugs 34 (2), 145-162, 2002 | 52 | 2002 |
Caveat emptor: editors beware FX Vollenweider, RT Jones, MJ Baggott Neuropsychopharmacology 24 (4), 461-463, 2001 | 51 | 2001 |
Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial JE Mendelson, JR Coyle, JC Lopez, MJ Baggott, K Flower, ET Everhart, ... Psychopharmacology 214, 933-939, 2011 | 47 | 2011 |
Psychedelics and creativity: a review of the quantitative literature MJ Baggott PeerJ preprints, 2015 | 44 | 2015 |
Ketamine is associated with lower urinary tract signs and symptoms R Pal, S Balt, E Erowid, F Erowid, MJ Baggott, J Mendelson, GP Galloway Drug and alcohol dependence 132 (1-2), 189-194, 2013 | 38 | 2013 |